Latin America represents an emerging hub for neuroscience research and biotechnology development, with Brazil leading regional efforts in Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders. This page documents companies, academic institutions, and research initiatives focused on neurodegeneration in the region.
The Latin American biotech landscape in neurodegeneration is characterized by:
The region has approximately 15 million people living with Alzheimer's disease and Parkinson's disease combined, creating significant demand for local research and treatment development [1]. Governments across Latin America have increased funding for neuroscience research, with Brazil's São Paulo Research Foundation (FAPESP) being a major supporter of neurodegeneration research [2].
Location: São Paulo, Brazil
Focus: Oncology and neuroscience
Recepta Biopharma is a Brazilian biotech developing antibody-based therapies. The company has expanded into neuroscience research, focusing on neuroinflammatory pathways in Alzheimer's disease.
Location: Guarulhos, São Paulo
Focus: Pharmaceutical development
Aché is one of Brazil's largest pharmaceutical companies with a growing neuroscience division. The company develops treatments for neurological disorders and collaborates with academic institutions on neurodegeneration research.
Location: São Paulo, Brazil
Focus: Generic pharmaceuticals and innovation
Eurofarma has expanded into specialty pharmaceuticals, including CNS drugs. The company invests in research on neurodegenerative disease treatments.
Location: São Paulo, Brazil
Focus: Pharmaceutical research
Bergamo participates in neuroscience research collaborations focusing on neuroprotective compounds.
Location: São Paulo, Brazil
USP is Brazil's leading research university with significant neuroscience programs:
The USP Memory Clinic conducts clinical trials for Alzheimer's disease treatments and maintains one of the largest AD patient registries in Latin America [3].
Location: Campinas, São Paulo, Brazil
UNICAMP is a leading research university with strong neuroscience programs:
The university's stem cell research program has shown promising results in preclinical models of Parkinson's disease [4].
Location: Rio de Janeiro, Brazil
UFRJ conducts significant neuroscience research:
Location: São Paulo, Brazil
UNIFESP is specialized in health sciences:
The IBN coordinates national neuroscience research efforts, including:
The São Paulo Research Foundation funds multiple neurodegeneration research programs:
Location: Buenos Aires, Argentina
Focus: Vaccine and biotech development
Sinergium has expanded beyond vaccines into neuroscience research, focusing on immunological approaches to neurodegenerative diseases.
Location: Buenos Aires, Argentina
Focus: Pharmaceutical development
Gador has a neuroscience division focused on CNS disorders:
Location: Buenos Aires, Argentina
UBA is Argentina's leading research university:
The university operates the Institute of Neurosciences that conducts both basic and clinical research on neurodegenerative diseases [5].
Location: La Plata, Argentina
Location: Mexico City, Mexico
Focus: Biotherapeutics
Probiosfera develops biological products with applications in neuroscience, focusing on regenerative medicine approaches.
Location: Mexico City, Mexico
Focus: Pharmaceutical research
Landsteiner develops treatments for CNS disorders:
Location: Mexico City, Mexico
UNAM is Mexico's leading research institution:
Location: Mexico City, Mexico
Mexico's premier neurology research hospital:
Location: Santiago, Chile
Focus: CNS drug development
Genzen is a Chilean biotech developing treatments for CNS disorders, including Alzheimer's and Parkinson's disease.
Location: Santiago, Chile
Focus: Biotech development
Savar works on biological therapies with applications in neurodegeneration:
Location: Santiago, Chile
University of Chile leads neuroscience research in Chile:
Location: Santiago, Chile
Location: Bogotá, Colombia
The university studies the Colombian paisa population, which has a high prevalence of early-onset Alzheimer's due to a specific mutation [6].
Location: Bogotá, Colombia
Location: Bogotá, Colombia
The LABRN coordinates neuroscience research across Latin America:
Latin American institutions collaborate with:
The Latin American neurodegeneration research sector is poised for significant growth. Key areas of focus include:
Regional initiatives such as the Latin American Alzheimer's Disease Initiative (LADSI) are working to establish standardized protocols and facilitate international collaboration. These efforts aim to position Latin America as a key player in global neurodegeneration research.